Insider: Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER - ACADIA PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 43,447 | 0 | 43,447 |
| Value | $912,387.00 | $0.00 | $912,387.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/15/2025 | DDS | 3,498 | Direct | COM | $23.65 | $82,727.70 | 43,447 |
| 08/18/2025 | DDS | 22,000 | Direct | COM | $25.18 | $554,023.80 | 40,130 |
| 05/16/2025 | DDS | 2,000 | Direct | COM | $25.00 | $50,000.00 | 62,130 |
| 05/02/2025 | DDS | 3,498 | Direct | COM | $14.60 | $51,070.80 | 62,773 |
| 04/08/2025 | DDS | 2,708 | Direct | COM | $14.82 | $40,132.56 | 59,456 |
| 03/26/2025 | DDS | 3,171 | Direct | COM | $17.05 | $54,065.55 | 56,889 |
| 02/24/2025 | DDS | 773 | Direct | COM | $19.96 | $15,429.08 | 53,882 |
| 11/19/2024 | DDS | 10,259 | Direct | COM | $16.81 | $172,453.79 | 53,302 |
| 08/19/2024 | DDS | 9,733 | Direct | COM | $15.28 | $148,720.24 | 43,735 |
| 06/10/2024 | DDS | 975 | Direct | COM | $14.79 | $14,420.25 | 34,564 |
| 05/02/2024 | DDS | 3,503 | Direct | COM | $16.94 | $59,340.82 | 32,053 |
| 04/08/2024 | DDS | 2,716 | Direct | COM | $17.87 | $48,534.92 | 28,742 |
| 03/27/2024 | DDS | 5,434 | Direct | COM | $17.90 | $97,268.60 | 26,183 |
| 02/26/2024 | DDS | 772 | Direct | COM | $24.67 | $19,045.24 | 21,067 |
| 11/20/2023 | DDS | 5,108 | Direct | COM | $22.64 | $115,645.12 | 20,486 |
| 08/21/2023 | DDS | 10,000 | Direct | COM | $29.00 | $289,970.00 | 15,682 |
| 06/08/2023 | DDS | 974 | Direct | COM | $25.02 | $24,369.48 | 22,824 |
| 05/17/2023 | DDS | 15,310 | Direct | COM | $22.50 | $344,475.00 | 21,905 |
| 04/06/2023 | DDS | 1,916 | Direct | COM | $18.16 | $34,794.56 | 7,477 |
| 02/24/2023 | DDS | 577 | Direct | COM | $18.78 | $10,836.06 | 4,118 |
| 06/09/2022 | DDS | 653 | Direct | COM | $17.91 | $11,694.90 | 3,342 |
| 02/23/2022 | DDS | 553 | Direct | COM | $23.80 | $13,161.40 | 2,102 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research